Intelligencer
The Cut
Vulture
The Strategist
Curbed
Grub Street
Magazine
Subscribe to the Magazine
Give a Gift Subscription
Buy Back Issues
Current Issue Contents
Subscribe
Sign In
Account
Profile
Sign Out
Menu
Menu
Close
Close
Politics
Business
Technology
About Intelligencer
Newsletters
Like Us
Follow Us
NYMag.com
New York Magazine
Intelligencer
Vulture
The Cut
The Strategist
Grub Street
Curbed
Search
Search
Close
Subscribe
Give A
Gift
Menu
Menu
Close
Close
Politics
Business
Technology
About Intelligencer
Newsletters
Like Us
Follow Us
NYMag.com
New York Magazine
Intelligencer
Vulture
The Cut
The Strategist
Grub Street
Curbed
+
Comments
Leave a Comment
Search
Search
Close
Displaying all articles tagged:
Pharma
interesting times
May 10, 2019
Andrew Sullivan: Who Should Be Allowed to Compete in Women’s Sports?
The debate is legitimate and important. But some of the arguments being made in major publications are patently false.
By
Andrew Sullivan
innovation
Sept. 7, 2018
OxyContin Billionaire Patents New Drug for Opioid Treatment
Richard Sackler made billions convincing Americans that OxyContin wasn’t addictive. Now, he’s going to make millions selling them addiction treatment.
By
Eric Levitz
June 1, 2017
Tom Price Bought Pharma Stocks — Then Lobbied for the Industry in Australia
The Health secretary’s blatant corruption grows even more blatant.
By
Eric Levitz
Jan. 31, 2017
Trump Meets Big-Pharma CEOs, Then Seems to Flip-flop on Negotiating Drug Prices
On the campaign trail he mocked the lobbyists. Today he sounded like one.
By
Ed Kilgore
Jan. 12, 2017
Why Cory Booker’s Midnight Vote on Drug Importation Is Getting So Much Attention
To the alarm of progressives, he is apparently bending to the interests of wealthy donors even as he is rising to Democratic stardom.
By
Ed Kilgore
Jan. 11, 2017
Trump Tanks Pharma Stocks With Sudden Threat to Fight High Drug Prices
In his first press conference, he revived a nearly forgotten plan to authorize government negotiations on pharmaceutical prices.
By
Ed Kilgore